PAA Members
Member Login

News

News / 16.04.2024

Pfizer is now offering preferred pricing to PAA members on PENBRAYA, the first and only pentavalent (5-in-1) MenABCWY vaccine. PENBRAYA offers the broadest protection against the 5 leading meningococcal serogroups (A, B, C, W, and Y) in a single vaccine product.  To learn more about Penbraya,...

News / 09.04.2024

Sanofi has announced its new Beyfortus Reservation Program designed to optimize planning and access to Beyfortus ahead of the 2024/2025 season, as well as unlock additional benefits. View the Beyfortus Reservation Program Brochure for more details and to learn how you can participate. Benefits of the Beyfortus...

News / 29.02.2024

Sanofi Updates on Beyfortus and MenQuadfi Beyfortus Available to Order Sanofi has advised that Beyfortus® (nirsevimab-alip) 50mg and 100mg Injection is still available to order on vaccineshop.com. Remaining [50 mg and 100 mg] doses can be ordered on a first come, first served basis. Please note any orders...

News / 23.01.2024

Pre-booking for the 2024-25 flu season is underway. Maximize your savings and delivery guarantee by pre-booking through one of our flu vaccine agreements with GSK, Sanofi or Seqirus. Log in to review the pre-booking discount information and to learn how to reserve your doses....

News / 03.10.2023

Liletta Approval Expanded to Include Treatment of Heavy Menstrual Bleeding In July, Medicines360, a global nonprofit organization with a mission to catalyze equitable access to quality medicines for women, announced that the FDA has approved its supplemental New Drug Application (sNDA) for the Liletta IUD for...

News / 26.09.2023

Did You Know? Currently PAA offers members vaccine savings opportunities through our direct agreements with GSK, Sanofi, Pfizer, Moderna and Seqirus. Ordering vaccines from the manufacturer through our direct contracts is a fast, cost-effective and reliable way to purchase vaccines. Once your practice completes the process to...

News / 07.09.2023

GSK has advised that flu vaccine doses are available to order now for PAA members who did not prebook. To Order: Go to gskdirect.com and place a prebook order for either Fluarix or Flulaval. GSK will process the order and practices can schedule a delivery within a...

News / 22.08.2023

Sanofi's Beyfortus Recommended for all Infants Following the news of FDA-approval of Beyfortus (nirsevimab-alip) in July, the ACIP has now recommended the use of Beyfortus for all infants. Beyfortus is indicated for the prevention of respiratory syncytial virus (RSV) lower respiratory tract disease in: ·     Neonates and infants...

News / 03.08.2023

You're invited to join the RSV National Expert Program to learn about a new FDA-approved option for infant RSV prevention: Spotlight on Beyfortus This 1-hour live panel discussion includes a scientific presentation followed by an interactive Q&A session with the opportunity to submit questions live. August 16th 7:00 p.m....